The lower target points to a less favorable estimate, but Macquarie kept its Outperform rating. The report cites market swings and no company business change, so these signals do not clearly shift Core Scientific's prospects.
A lower target points to a less favorable estimate, but the unchanged rating still favors the shares. The report cites industry stock swings, not a change in Core Scientific's business. These points do not give a clear reason to change its prospects.
Follow Core Scientific, Inc. (CORZ) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CORZ